Status:
COMPLETED
Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)
Lead Sponsor:
Neothetics, Inc
Conditions:
Thyroid-Related Eye Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This is a pilot study to determine the safety and efficacy of orbital injections of LIPO-102.
Eligibility Criteria
Inclusion
- Male or Non pregnant female
- Symptomatic exophthalmos
- Inactive Thyroid Eye Disease
- Signed informed consent
Exclusion
- Known hypersensitivity to study drugs
- Treatment with an investigational agent within 30 days of first dose
- History of Thyroid Eye Disease less than 6 months
- Previous decompression surgery
- Glaucoma
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00954057
Start Date
September 1 2009
End Date
June 1 2011
Last Update
March 26 2015
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Adelaide, Australia
2
Brisbane, Australia
3
Melbourne, Australia
4
Sydney, Australia